EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:EKF
- CUSIP: N/A
- Web: N/A
- Market Cap: £96.33 million
- Outstanding Shares: 464,262,000
- 50 Day Moving Avg: GBX 21.22
- 200 Day Moving Avg: GBX 18.80
- 52 Week Range: GBX 10.50 - GBX 21.88
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: £38.59 million
- Price / Sales: 2.50
- Book Value: GBX 0.13 per share
- Price / Book: 1.60
- Average Volume: 1.40 million shs.
Frequently Asked Questions for Ekf Diagnostics Holding PLC (LON:EKF)
What is Ekf Diagnostics Holding PLC's stock symbol?
Ekf Diagnostics Holding PLC trades on the London Stock Exchange (LON) under the ticker symbol "EKF."
Where is Ekf Diagnostics Holding PLC's stock going? Where will Ekf Diagnostics Holding PLC's stock price be in 2017?
1 equities research analysts have issued 1 year price targets for Ekf Diagnostics Holding PLC's shares. Their forecasts range from GBX 19 to GBX 21. On average, they anticipate Ekf Diagnostics Holding PLC's stock price to reach GBX 20 in the next year. View Analyst Ratings for Ekf Diagnostics Holding PLC.
Who are some of Ekf Diagnostics Holding PLC's key competitors?
Some companies that are related to Ekf Diagnostics Holding PLC include Tiziana Life Sciences PLC (TILS), Anglo Pacific Group plc (APF), Microgen plc (MCGN), Gemfields PLC (GEM), Vertu Motors Plc (VTU), Shield Therapeutics PLC (STX), Gateley Holdings PLC (GTLY), Tribal Group plc (TRB), Cohort PLC (CHRT), Wandisco PLC (WAND), Topps Tiles Plc (TPT), Findel plc (FDL), Charles Stanley Group plc (CAY), Huntsworth plc (HNT), Somero Enterprises (SOM), James Latham plc (LTHM), Acal plc (ACL) and Rhythmone PLC (RTHM).
How do I buy Ekf Diagnostics Holding PLC stock?
Shares of Ekf Diagnostics Holding PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Ekf Diagnostics Holding PLC stock cost?
One share of Ekf Diagnostics Holding PLC stock can currently be purchased for approximately GBX 20.75.
Earnings History for Ekf Diagnostics Holding PLC (LON:EKF)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Ekf Diagnostics Holding PLC (LON:EKF)
Current Year EPS Consensus Estimate: $0.75 EPS
Dividend History for Ekf Diagnostics Holding PLC (LON:EKF)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Ekf Diagnostics Holding PLC (LON:EKF)Insider Trades by Quarter for Ekf Diagnostics Holding PLC (LON:EKF)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|3/20/2017||Christopher H B Mills||Insider||Buy||8,000,000||GBX 19||£1,520,000|
|7/15/2016||Mills,Christopher H B||Insider||Buy||9,000,000||GBX 15||£1,350,000|
|6/24/2016||Mills,Christopher H B||Insider||Buy||2,613,957||GBX 12||£313,674.84|
|6/23/2016||Mills,Christopher H B||Insider||Buy||2,000,000||GBX 12||£240,000|
|6/21/2016||Mills,Christopher H B||Insider||Buy||4,500,000||GBX 12||£540,000|
|6/17/2016||Mills,Christopher H B||Insider||Buy||532,781||GBX 12||£63,933.72|
|6/9/2016||Mills,Christopher H B||Insider||Buy||447,666||GBX 12||£53,719.92|
Headline Trends for Ekf Diagnostics Holding PLC (LON:EKF)
Latest Headlines for Ekf Diagnostics Holding PLC (LON:EKF)
Ekf Diagnostics Holding PLC (EKF) Chart for Friday, May, 26, 2017